BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 10379743)

  • 1. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Repeat transurethral resection for non-muscle invasive bladder cancer].
    Shen YJ; Ye DW; Yao XD; Zhang SL; Dai B; Zhu YP; Zhang HL; Zhu Y; Shi GH; Ma CG
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):725-7. PubMed ID: 19615201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A; Buettner R; Jakse G
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?
    Divrik T; Yildirim U; Eroğlu AS; Zorlu F; Ozen H
    J Urol; 2006 Apr; 175(4):1258-61. PubMed ID: 16515974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors.
    Aydin M; Tandogdu Z; Kurtulus FO; Avci E; Fazlioglu A; Cek M
    J BUON; 2010; 15(3):514-7. PubMed ID: 20941820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results.
    Ugurlu O; Gonulalan U; Adsan O; Kosan M; Oztekin V; Cetinkaya M
    Urology; 2007 Jul; 70(1):55-9. PubMed ID: 17656208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second-look TUR in T1 transitional cell carcinoma: why?
    Jakse G; Algaba F; Malmström PU; Oosterlinck W
    Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early complications of endoscopic treatment for superficial bladder tumors.
    Collado A; Chéchile GE; Salvador J; Vicente J
    J Urol; 2000 Nov; 164(5):1529-32. PubMed ID: 11025697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A technique for resection of small bladder tumors using a flexible cystoscope on an outpatient basis: bladder tumor resection with newly designed hot cup forceps.
    Muraishi O; Mitsu S; Suzuki K; Koshimizu T; Tokue A
    J Urol; 2001 Nov; 166(5):1817-9. PubMed ID: 11586231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.